Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionFormidable Asset Management, LLC
Latest Disclosed Ownership5,466 shares
Latest Disclosed Value $ 321,445
Formidable Asset Management, LLC reports 11.58% decrease in ownership of TECH / Bio-Techne Corporation

On April 22, 2026 - Formidable Asset Management, LLC filed a 13F-HR form disclosing ownership of 5,466 shares of Bio-Techne Corporation (US:TECH) valued at $285,653 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 6,182 shares of Bio-Techne Corporation. This represents a change in shares of -11.58% during the quarter. The current value of the position is $277,946 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F BIO-TECHNE COM 09073M104 5,466 -716 -11.58 321 -6.41 0.0496
2026-01-16 2025-12-31 13F BIO-TECHNE COM 09073M104 6,182 -3,509 -36.21 344 -31.12 0.0500
2025-10-29 2025-09-30 13F BIO-TECHNE COM 09073M104 9,691 -768 -7.34 499 -18.76 0.0785
2025-07-16 2025-06-30 13F BIO-TECHNE COM 09073M104 10,459 0 0.00 613 0.00 0.1026
2025-05-05 2025-03-31 13F BIO-TECHNE COM 09073M104 10,459 -740 -6.61 613 -23.95 0.1025
2025-02-19 2024-12-31 13F BIO-TECHNE COM 09073M104 11,199 -1,238 -9.95 807 -18.91 0.1325
2024-11-12 2024-09-30 13F BIO-TECHNE COM 09073M104 12,437 -2,977 -19.31 994 -9.96 0.1588
2024-08-08 2024-06-30 13F BIO-TECHNE COM 09073M104 15,414 -1,430 -8.49 1,104 -6.84 0.1786
2024-05-15 2024-03-31 13F BIO-TECHNE COM 09073M104 16,844 -1,685 -9.09 1,186 -17.07 0.1933
2024-02-07 2023-12-31 13F BIO-TECHNE COM 09073M104 18,529 -558 -2.92 1,430 10.01 0.2969
2023-11-09 2023-09-30 13F BIO-TECHNE COM 09073M104 19,087 16 0.08 1,299 129,800.00 0.2878
2023-08-15 2023-06-30 13F BIO-TECHNE CORP COM COM 09073M104 19,071 -979 -4.88 2 0.00 0.3398
2023-05-09 2023-03-31 13F BIO-TECHNE CORP COM COM 09073M104 20,050 -52 -0.26 1 0.00 0.3125
2023-02-07 2022-12-31 13F BIO-TECHNE CORP COM COM 09073M104 20,102 14,986 292.92 2 -99.93 0.3764
2022-11-14 2022-09-30 13F BIO-TECHNE COM 09073M104 5,116 -655 -11.35 1,519 -24.20 0.3523
2022-08-18 2022-06-30 13F/A-1 BIO-TECHNE COM 09073M104 5,771 -180 -3.02 2,004 -22.24 0.4511
2022-08-16 2022-06-30 13F BIO-TECHNE COM 09073M104 5,771 -180 2,004 0.4654
2022-05-04 2022-03-31 13F BIO-TECHNE COM 09073M104 5,951 -1,974 -24.91 2,577 -30.84 0.4941
2022-02-07 2021-12-31 13F BIO-TECHNE CORP COM COM 09073M104 7,925 -223 -2.74 3,726 -5.62 0.7150
2021-11-10 2021-09-30 13F BIO-TECHNE CORP COM COM 09073M104 8,148 -142 -1.71 3,948 3.92 0.7415
2021-08-16 2021-06-30 13F/A-2 BIO-TECHNE CORP COM Common Stock 09073M104 8,290 -119 -1.42 3,799 16.53 0.8157
2021-08-06 2021-06-30 13F BIO-TECHNE CORP COM COM 09073M104 316 -8,093 3,723 0.8772
2021-05-12 2021-03-31 13F BIO-TECHNE CORP COM COM 09073M104 8,409 -233 -2.70 3,260 19.85 0.7086
2021-01-29 2020-12-31 13F BIO-TECHNE CORP COM COM 09073M104 8,642 -51 -0.59 2,720 26.69 0.6303
2020-12-14 2020-09-30 13F/A-1 BIO-TECHNE Equity 09073M104 8,693 -218 -2.45 2,147 -12.01 0.6258
2020-11-13 2020-09-30 13F BIO-TECHNE CORP COM COM 09073M104 8,693 -218 2,147 584,816.0295
2020-08-13 2020-06-30 13F BIO-TECHNE Equity 09073M104 8,911 -296 -3.21 2,440 39.83 0.7196
2020-06-01 2020-03-31 13F BIO-TECHNE Common 09073M104 9,207 -565 -5.78 1,745 -19.36 0.6870
2020-02-13 2019-12-31 13F BIO-TECHNE CORP COM COM 09073M104 9,772 9,772 2,164 0.6822
2019-11-08 2019-09-30 13F BIO-TECHNE CORP COM COM 09073M104 0 -9,532 -100.00 0 -100.00
2019-10-15 2019-06-30 13F BIO-TECHNE CORP COM COM 09073M104 9,532 9,532 2,003 0.6888
2018-02-13 2017-12-31 13F BIO TECHNE Common 09073M104 0 -8,549 -100.00 0 -100.00
2017-11-13 2017-09-30 13F BIO TECHNE Common 09073M104 8,549 87 1.03 1,033 3.92 0.4359
2017-08-11 2017-06-30 13F BIO TECHNE Common 09073M104 8,462 188 2.27 994 8.99 0.4902
2017-05-12 2017-03-31 13F BIO TECHNE Common 09073M104 8,274 763 10.16 912 18.13 0.3976
2017-02-08 2016-12-31 13F BIO TECHNE Common 09073M104 7,511 -32 -0.42 772 -6.54 0.3900
2016-11-14 2016-09-30 13F BIO TECHNE Common 09073M104 7,543 420 5.90 826 4.03 0.4105
2016-08-12 2016-06-30 13F BIO TECHNE Common 09073M104 7,123 7,123 794 0.4419
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.